π Stay ahead with AI and receive:
β
Access our Free Community and join 400K+ professionals learning AI
β 35% Discount for ChatNode
BenevolentAI uses AI to accelerate biopharma drug discovery and provide life science intelligence.
BenevolentAI (Euronext Amsterdam: BAI) is a company that applies advanced AI to accelerate biopharma drug discovery. Their next-generation platform targets the complex decisions that drive R&D, providing life science intelligence. They build technology in the service of science, bringing together science and technology teams to push AI and machine learning to new limits. They leverage their knowledge graph and proprietary ontologies to support scientists and executives in leveraging cutting-edge AI with confidence and precision.
Research & Insights
AI-driven drug discovery platform; Knowledge graph and proprietary ontologies; Life science intelligence
Every week, our team highlights tools solving real business problemsβhereβs a quick peek.
π Stay ahead with AI and receive:
β
Access our Free Community and join 400K+ professionals learning AI
β
35% Discount for ChatNode
π Stay ahead with AI and receive:
β
Access our Free Community and join 400K+ professionals learning AI
β 35% Discount for ChatNode